These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 29356436)

  • 1. Health insurance and use of recommended routine care in adults with cystic fibrosis.
    Li SS; Hayes D; Tobias JD; Morgan WJ; Tumin D
    Clin Respir J; 2018 May; 12(5):1981-1988. PubMed ID: 29356436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pulmonary exacerbation risk score among cystic fibrosis patients not receiving recommended care.
    Sawicki GS; Ayyagari R; Zhang J; Signorovitch JE; Fan L; Swallow E; Latremouille-Viau D; Wu EQ; Shi L
    Pediatr Pulmonol; 2013 Oct; 48(10):954-61. PubMed ID: 23255309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced mortality in cystic fibrosis patients treated with tobramycin inhalation solution.
    Sawicki GS; Signorovitch JE; Zhang J; Latremouille-Viau D; von Wartburg M; Wu EQ; Shi L
    Pediatr Pulmonol; 2012 Jan; 47(1):44-52. PubMed ID: 21815282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial efficacy of tobramycin polymeric nanoparticles for Pseudomonas aeruginosa infections in cystic fibrosis: formulation, characterisation and functionalisation with dornase alfa (DNase).
    Deacon J; Abdelghany SM; Quinn DJ; Schmid D; Megaw J; Donnelly RF; Jones DS; Kissenpfennig A; Elborn JS; Gilmore BF; Taggart CC; Scott CJ
    J Control Release; 2015 Jan; 198():55-61. PubMed ID: 25481442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Geographic variations in cystic fibrosis: An analysis of the U.S. CF Foundation Registry.
    Kopp BT; Nicholson L; Paul G; Tobias J; Ramanathan C; Hayes D
    Pediatr Pulmonol; 2015 Aug; 50(8):754-62. PubMed ID: 25825016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of the affordable care act dependent coverage provision on patients with cystic fibrosis.
    Tumin D; Li SS; Kopp BT; Kirkby SE; Tobias JD; Morgan WJ; Hayes D
    Pediatr Pulmonol; 2017 Apr; 52(4):458-466. PubMed ID: 28152283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic fibrosis clinical characteristics associated with dornase alfa treatment regimen change.
    VanDevanter DR; Craib ML; Pasta DJ; Millar SJ; Morgan WJ; Konstan MW;
    Pediatr Pulmonol; 2018 Jan; 53(1):43-49. PubMed ID: 29064184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to dornase alfa treatment among commercially insured patients with cystic fibrosis.
    Nasr SZ; Chou W; Villa KF; Chang E; Broder MS
    J Med Econ; 2013; 16(6):801-8. PubMed ID: 23506540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A crossover, randomized, controlled trial of dornase alfa before versus after physiotherapy in cystic fibrosis.
    Fitzgerald DA; Hilton J; Jepson B; Smith L
    Pediatrics; 2005 Oct; 116(4):e549-54. PubMed ID: 16147970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Factors for Gaps in Care during Transfer from Pediatric to Adult Cystic Fibrosis Programs in the United States.
    Sawicki GS; Ostrenga J; Petren K; Fink AK; D'Agostino E; Strassle C; Schechter MS; Rosenfeld M
    Ann Am Thorac Soc; 2018 Feb; 15(2):234-240. PubMed ID: 29220199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tobramycin inhalation powder: an efficient and efficacious therapy for the treatment of Pseudomonas aeruginosa infection in cystic fibrosis.
    Somayaji R; Parkins MD
    Ther Deliv; 2015 Feb; 6(2):121-37. PubMed ID: 25690082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between the introduction of a new cystic fibrosis inhaled antibiotic class and change in prevalence of patients receiving multiple inhaled antibiotic classes.
    Dasenbrook EC; Konstan MW; VanDevanter DR
    J Cyst Fibros; 2015 May; 14(3):370-5. PubMed ID: 25496726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities.
    Quan JM; Tiddens HA; Sy JP; McKenzie SG; Montgomery MD; Robinson PJ; Wohl ME; Konstan MW;
    J Pediatr; 2001 Dec; 139(6):813-20. PubMed ID: 11743506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Mortality in Adult Cystic Fibrosis Patients with Medicaid Insurance Awaiting Lung Transplantation.
    Krivchenia K; Tumin D; Tobias JD; Hayes D
    Lung; 2016 Oct; 194(5):799-806. PubMed ID: 27510183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter Observational Study on Factors and Outcomes Associated with Various Methicillin-Resistant Staphylococcus aureus Types in Children with Cystic Fibrosis.
    Muhlebach MS; Heltshe SL; Popowitch EB; Miller MB; Thompson V; Kloster M; Ferkol T; Hoover WC; Schechter MS; Saiman L;
    Ann Am Thorac Soc; 2015 Jun; 12(6):864-71. PubMed ID: 25745825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dornase alfa (Pulmozyme).
    Wagener JS; Kupfer O
    Curr Opin Pulm Med; 2012 Nov; 18(6):609-14. PubMed ID: 22990660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome evaluation of a pharmacy-based therapy management program for patients with cystic fibrosis.
    Kirkham HS; Staskon F; Hira N; McLane D; Kilgore KM; Parente A; Kim S; Sawicki GS
    Pediatr Pulmonol; 2018 Jun; 53(6):720-727. PubMed ID: 29512893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No survival benefit to gaining private health insurance coverage for post-lung transplant care in adults with cystic fibrosis.
    Tumin D; Foraker RE; Tobias JD; Hayes D
    Clin Transplant; 2016 Mar; 30(3):320-7. PubMed ID: 26782769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nebulized tobramycin in the treatment of adult CF pulmonary exacerbations.
    Al-Aloul M; Nazareth D; Walshaw M
    J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):299-305. PubMed ID: 24219814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving evidence-based care in cystic fibrosis through quality improvement.
    McPhail GL; Weiland J; Acton JD; Ednick M; Chima A; VanDyke R; Fenchel MC; Amin RS; Seid M
    Arch Pediatr Adolesc Med; 2010 Oct; 164(10):957-60. PubMed ID: 20921354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.